期刊文献+

兔抗人TGF-β_1多克隆抗体的制备

Preparation of the Rabbit-anti-human TGF-β_1 Polyclonal Antibody
在线阅读 下载PDF
导出
摘要 目的以人重组TGF-β1蛋白作为抗原,制备兔抗人TGF-β1多克隆抗体。方法重组蛋白与弗氏佐剂等体积混匀,免疫新西兰白兔,获得兔抗人TGF-β1多克隆抗血清。饱和硫酸铵盐析法纯化多克隆抗体,间接酶联免疫吸附试验检测多克隆抗体效价,Western-blot技术进行抗体特异性检测。结果成功获得兔抗人TGF-β1多克隆抗体,纯化后抗体效价达1∶110 000。结论获得的兔抗人TGF-β1多克隆抗体具有良好的特异性,能满足进一步实验的需要。 Objective To prepare the rabbit-anti-human TGF-β1 polyclonal antibody from the immune rabbit with human TGF-β1 recombinant protein.Methods Equal volume of Freund′s adjuvant and recombinant protein were mixed,then New Zealand white rabbits were immunized with the the recombinant protein as antigen.The immune sera of rabbits were collected.Then antibody was purified by ammonium sulfate fractionation,then the polyclonal antibodies titer was detected by the indirect Enzyme-linked immunosorbent assay.Western-blot techniques was used to identify antibody specificity.Results The rabbit-anti-human TGF-β1 polyclonal antibody were successfully obtained.Purified rabbit anti-human polyclonal antibodies titer is 1∶ 10 000.Conclusion The specificity of rabbit anti-human TGF-β1 polyclonal antibodies is better to meet the need of further experiments.
出处 《医学综述》 2011年第16期2509-2510,共2页 Medical Recapitulate
基金 黑龙江省自然科学基金(D2007-99)
关键词 转化生长因子Β1 抗纤维化 多克隆抗体 Transforming growth factor-β1 Anti-fibrosis Polyclonal antibody
  • 相关文献

参考文献9

二级参考文献17

  • 1汪燕芳,彭进,蔡引凤,倪亚明,赵建阳,成国祥.抗rhEPO单克隆抗体的制备及初步应用[J].细胞与分子免疫学杂志,2004,20(6):696-698. 被引量:4
  • 2李文珠,陶惠然,颜江华,张长弓,苏金华,王阶平,杨桂旺,庄国洪.诱骗受体DcR3的基因构建、表达及特异性鉴定[J].细胞与分子免疫学杂志,2006,22(2):151-153. 被引量:3
  • 3Schnur J, Oláh J, Szepesi A, et al. Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice. Eur J Gastroenterol Hepatol, 2004, 16: 127-133.
  • 4Kondou H, Mushiake S, Etani Y, et al. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol, 2003, 39:742-748.
  • 5Yata Y, Gotwals P, Koteliansky V, et al. Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor:Implications for antifibrotic therapy. Hepatology, 2002, 35:1022-1030.
  • 6Strausberg RL, Feingold EA, Grouse LH, et al. Generation and initial analysis of more than 15 000 full-length human and cDNA sequences. Proc Natl Acad Sci USA, 2002, 99:16899-16903.
  • 7Wei YQ, Huang MJ, Yang L, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA, 2001,98 : 11545-11550.
  • 8Su JM, Wei YQ, Tian L, et al. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2. Cancer Res, 2003, 63: 600-607.
  • 9Vernersson M, Ledin A, Johansson J, et al. Generation of therapeutic antibody responses against IgE through vaccination.Faseb J, 2002, 16: 875-877.
  • 10Zhang, K., Garner W, Cohen L,et al. Increased types Ⅰ and Ⅲ collagen a nd transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar [J].Invest. Dermatol,1995,104:750.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部